Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Constipation | Research

Prevalence and factors associated with hypothyroidism in children with sickle cell anemia aged 6 months − 17 years attending the Sickle Cell Clinic, Mulago Hospital, Uganda; a cross-sectional study

Authors: Gloria Kaudha, Thereza Piloya, Victor Musiime, Mary Goretty Kuteesa, Shamimu Namugerwa, Gloria Owomugisha, Stella Alinafe Wachepa, Sanyu Kirabo Lubwama, Sarah Kiguli, James K Tumwine

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Purpose

Hypothyroidism has been reported at a prevalence of 6% in children and adolescents with Sickle cell anemia. In this study, we determined the prevalence and factors associated with hypothyroidism among children with Sickle cell anemia attending the Sickle Cell Clinic, in Mulago hospital, Uganda.

Methods

A cross-sectional study was conducted among children aged 6 months − 17 years with a confirmed diagnosis of Sickle Cell Anemia, with no prior diagnosis of hypothyroidism and in steady state attending the Sickle Cell Clinic in Mulago hospital. Data was collected using a structured questionnaire and a blood sample was used to measure thyroid stimulating hormone and free thyroxine.

Results

Of the 332 children enrolled, sixty (18.1%) participants had sub-clinical hypothyroidism (95% CI: 14.3 — 22.6). Factors associated with hypothyroidism included constipation [adjusted odds ratio: 3.1, 95% CI:1.0 — 9.0, p = 0.043] and male sex [adjusted odds ratio:2.0, 95% CI:1.1— 3.5, p = 0.025].

Conclusion

Approximately 1 in 5 children (18.1%) had sub-clinical hypothyroidism. Males and children who presented with constipation were more likely to have sub-clinical hypothyroidism.
Literature
1.
go back to reference Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. The Lancet. 2013;381(9861):142–51.CrossRef Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. The Lancet. 2013;381(9861):142–51.CrossRef
2.
go back to reference World Health A. Sickle-cell anaemia: report by the Secretariat. Geneva: World Health Organization; 2006. World Health A. Sickle-cell anaemia: report by the Secretariat. Geneva: World Health Organization; 2006.
3.
go back to reference Organization WH. Management of haemoglobin disorders: report of a joint WHO-TIF meeting, Nicosia, Cyprus, 16–18 November 2007. 2008. Organization WH. Management of haemoglobin disorders: report of a joint WHO-TIF meeting, Nicosia, Cyprus, 16–18 November 2007. 2008.
4.
go back to reference Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality. American Journal of Preventive Medicine. 2011;41(6, Supplement 4):S398-S405. Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality. American Journal of Preventive Medicine. 2011;41(6, Supplement 4):S398-S405.
5.
go back to reference Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study. The Lancet Global health. 2016;4(3):e195–200.CrossRefPubMed Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study. The Lancet Global health. 2016;4(3):e195–200.CrossRefPubMed
6.
go back to reference Hagag AA, El-Asy HM, Badraia IM, Hablas NM, El-Latif AEA. Thyroid Function in Egyptian Children with Sickle Cell Anemia in Correlation with Iron Load. Endocrine, metabolic & immune disorders drug targets. 2019;19(1):46–52. Hagag AA, El-Asy HM, Badraia IM, Hablas NM, El-Latif AEA. Thyroid Function in Egyptian Children with Sickle Cell Anemia in Correlation with Iron Load. Endocrine, metabolic & immune disorders drug targets. 2019;19(1):46–52.
7.
go back to reference Parshad O, Stevens MCG, Hudson C, Rosenthal J, Melville GN, Dunn DT, et al. Abnormal thyroid hormone and thyrotropin levels in homozygous sickle cell disease. Clin Lab Haematol. 1989;11(4):309–15.CrossRefPubMed Parshad O, Stevens MCG, Hudson C, Rosenthal J, Melville GN, Dunn DT, et al. Abnormal thyroid hormone and thyrotropin levels in homozygous sickle cell disease. Clin Lab Haematol. 1989;11(4):309–15.CrossRefPubMed
8.
go back to reference Fung EB, Harmatz PR, Lee PDK, Milet M, Bellevue R, Jeng MR, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006;135(4):574–82.CrossRefPubMed Fung EB, Harmatz PR, Lee PDK, Milet M, Bellevue R, Jeng MR, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006;135(4):574–82.CrossRefPubMed
9.
go back to reference Garadah TS, Jaradat AA, Alalawi ME, Hassan AB. Hormonal and echocardiographic abnormalities in adult patients with sickle-cell anemia in Bahrain. J blood Med. 2016;7:283–9.CrossRefPubMedPubMedCentral Garadah TS, Jaradat AA, Alalawi ME, Hassan AB. Hormonal and echocardiographic abnormalities in adult patients with sickle-cell anemia in Bahrain. J blood Med. 2016;7:283–9.CrossRefPubMedPubMedCentral
10.
11.
go back to reference Ozen S, Unal S, Erçetin N, Taşdelen B. Frequency and risk factors of endocrine complications in turkish children and adolescents with sickle cell anemia. Turkish J haematology: official J Turkish Soc Haematol. 2013;30(1):25–31.CrossRef Ozen S, Unal S, Erçetin N, Taşdelen B. Frequency and risk factors of endocrine complications in turkish children and adolescents with sickle cell anemia. Turkish J haematology: official J Turkish Soc Haematol. 2013;30(1):25–31.CrossRef
12.
go back to reference Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet (London England). 2010;376(9757):2018–31.CrossRefPubMed Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet (London England). 2010;376(9757):2018–31.CrossRefPubMed
13.
go back to reference Phillips G Jr, Becker B, Keller VA, Hartman Iv J. Hypothyroidism in adults with sickle cell anemia. Am J Med. 1992;92(5):567–70.CrossRefPubMed Phillips G Jr, Becker B, Keller VA, Hartman Iv J. Hypothyroidism in adults with sickle cell anemia. Am J Med. 1992;92(5):567–70.CrossRefPubMed
14.
go back to reference Evliyaoglu N, Kilinc Y, Sargin O. Thyroid functions in mild and severe forms of sickle cell anemia. Pediatr Int J. 1996;38(5):460–3.CrossRef Evliyaoglu N, Kilinc Y, Sargin O. Thyroid functions in mild and severe forms of sickle cell anemia. Pediatr Int J. 1996;38(5):460–3.CrossRef
15.
go back to reference Scheaffer RL, Mendenhall W III, Ott RL, Gerow KG. Elementary survey sampling. Belmont, California: Duxbury Press; 1990. Scheaffer RL, Mendenhall W III, Ott RL, Gerow KG. Elementary survey sampling. Belmont, California: Duxbury Press; 1990.
16.
go back to reference El-Hazmi MAF, Bahakim HM, Al-Fawaz I. Endocrine functions in Sickle Cell Anaemia Patients. J Trop Pediatr. 1992;38(6):307–13.CrossRefPubMed El-Hazmi MAF, Bahakim HM, Al-Fawaz I. Endocrine functions in Sickle Cell Anaemia Patients. J Trop Pediatr. 1992;38(6):307–13.CrossRefPubMed
17.
go back to reference ElAlfy MS, El-Sherif NH, Sakr HM, El Ashkar MNM. Thyroid hemodynamic alterations in egyptian patients with sickle cell disease: relation to disease severity, total body iron and thyroid function. Expert Rev Hematol. 2019;12(8):589–96.CrossRefPubMed ElAlfy MS, El-Sherif NH, Sakr HM, El Ashkar MNM. Thyroid hemodynamic alterations in egyptian patients with sickle cell disease: relation to disease severity, total body iron and thyroid function. Expert Rev Hematol. 2019;12(8):589–96.CrossRefPubMed
18.
go back to reference Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76–131.CrossRefPubMed Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76–131.CrossRefPubMed
19.
go back to reference Soliman AT, De Sanctis V, Yassin M, Wagdy M, Soliman N. Chronic anemia and thyroid function. Acta bio-medica: Atenei Parmensis. 2017;88(1):119–27.PubMed Soliman AT, De Sanctis V, Yassin M, Wagdy M, Soliman N. Chronic anemia and thyroid function. Acta bio-medica: Atenei Parmensis. 2017;88(1):119–27.PubMed
20.
go back to reference Zekavat OR, Makarem AR, Haghpanah S, Karamizadeh Z, Javad P, Karimi M. Hypothyroidism in β-Thalassemia Intermedia patients with and without Hydroxyurea. Iran J Med Sci. 2014;39(1):60–3.PubMedPubMedCentral Zekavat OR, Makarem AR, Haghpanah S, Karamizadeh Z, Javad P, Karimi M. Hypothyroidism in β-Thalassemia Intermedia patients with and without Hydroxyurea. Iran J Med Sci. 2014;39(1):60–3.PubMedPubMedCentral
21.
go back to reference Masika L, Hsieh M, Zhao Z, Yu X, Soldin S. Are we Missing Hypothyroidism in Sickle Cell Disease.Ann Clin Case Rep2017;2. 2017;1246. Masika L, Hsieh M, Zhao Z, Yu X, Soldin S. Are we Missing Hypothyroidism in Sickle Cell Disease.Ann Clin Case Rep2017;2. 2017;1246.
22.
go back to reference Gallizzi R, Crisafulli C, Aversa T, Salzano G, De Luca F, Valenzise M, et al. Subclinical hypothyroidism in children: is it always subclinical? Ital J Pediatr. 2018;44(1):25.CrossRefPubMedPubMedCentral Gallizzi R, Crisafulli C, Aversa T, Salzano G, De Luca F, Valenzise M, et al. Subclinical hypothyroidism in children: is it always subclinical? Ital J Pediatr. 2018;44(1):25.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence and factors associated with hypothyroidism in children with sickle cell anemia aged 6 months − 17 years attending the Sickle Cell Clinic, Mulago Hospital, Uganda; a cross-sectional study
Authors
Gloria Kaudha
Thereza Piloya
Victor Musiime
Mary Goretty Kuteesa
Shamimu Namugerwa
Gloria Owomugisha
Stella Alinafe Wachepa
Sanyu Kirabo Lubwama
Sarah Kiguli
James K Tumwine
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01317-2

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine